Navigation Links
Cholesterol drug may have role in treating prostate cancer
Date:9/20/2010

TORONTO, Ont., Sept. 20, 2010 A drug commonly prescribed for people with high cholesterol may also be effective in treating prostate cancer, according to new research by Dr. Xiao-Yan Wen at St. Michael's Hospital.

Rosuvastatina statin drug sold as Crestorsuppressed the growth of transplanted human prostate cancer cells in mice.

"Our data provided solid pre-clinical evidence and a strong rationale for clinical trials of statins in the treatment of prostate cancer," said Wen, whose research appears in the September issue of European Urology, the journal of the European Association of Urology.

Prostate cancer is the most common cancer in Canadian men one in seven men will develop the disease during his lifetime and one in 27 will die from it. Despite improvements in treatments such as surgery, radiation and chemotherapy, many patients still progress to advanced stages.

Recent clinical trials have shown encouraging results regarding the use of angiogenic inhibitorssubstances that prevent the growth of blood vessels that feed tumors.

Wen and his colleagues in Canada and China screened 2,000 small molecules in zebrafish embryos with 2,000 small molecules. Seven compoundsfour of them statinsslowed or prevented the growth of those blood vessels. They then decided to investigate the cancer-fighting potential of one of those statins, rosuvastatin, and found it suppressed the growth of prostate cancer in mice without apparent side effects.

If human trials confirmed that statin drugs can optimize the benefits of radiation, that would help doctors determine the most effective, less toxic and affordable treatments for their prostate cancer patients.


'/>"/>

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital
Source:Eurekalert

Page: 1

Related medicine news :

1. Compounds in non-stick cookware may be associated with elevated cholesterol in children and teens
2. Chemicals in Rugs, Cookware May Be Linked to Raised Cholesterol in Teens
3. Study Suggests Statins Could Help Some With Normal Cholesterol
4. Cholesterol Levels Fluctuate With Menstrual Cycle
5. Genome Studies Point to Cholesterol-Regulating Genes
6. High Cholesterol in Youth Boosts Heart Risk In Middle Age
7. No firm conclusions about HDL cholesterol can be drawn from JUPITER sub-analysis
8. Some on Statins May Not Need Boost in Good Cholesterol
9. New links between cholesterol and depression in the elderly
10. Screening Guidelines Miss Many Kids With High Cholesterol
11. Good HDL Cholesterol Now Tied to Lower Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
Breaking Medicine Technology: